MEMPHIS PHARMACEUTICALSMEMPHIS PHARMACEUTICALSMEMPHIS PHARMACEUTICALS

MEMPHIS PHARMACEUTICALS

No trades
See on Supercharts

MPCI fundamentals

MEMPHIS PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of MPCI for the last quarter is 207.33 M EGP, and it's 11.70% lower compared to the previous quarter. The net income of Q4 24 is 25.09 M EGP.

Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth